Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:47 pm Purchase | 2025-02-03 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management, LLC | 254,639 15.990% | 7 (+0.00%) | Filing History |
| 2024-11-14 1:08 pm Purchase | 2024-09-30 | 13G | Evoke Pharma, Inc. EVOK | LYTTON LAURENCE W | 74,757 9.990% | 74,757 (New Position) | Filing History |
| 2024-11-14 09:19 am Purchase | 2024-09-30 | 13G | Evoke Pharma, Inc. EVOK | Altium Capital Management LLC | 153,186 4.990% | 153,186 (New Position) | Filing History |
| 2024-11-06 4:31 pm Purchase | 2024-11-06 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management, LLC | 254,632 15.990% | 169,946 (+200.68%) | Filing History |
| 2024-10-29 7:47 pm Unchanged | 2024-10-29 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-10-01 4:53 pm Unchanged | 2024-09-27 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management, LLC | 84,686 10.000% | 0 (Unchanged) | Filing History |
| 2024-09-20 7:28 pm Purchase | 2024-09-20 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management, LLC | 84,686 10.000% | 84,686 (New Position) | Filing History |
| 2024-03-13 1:32 pm Purchase | 2024-02-09 | 13G | Evoke Pharma, Inc. EVOK | LYTTON LAURENCE W | 71,610 9.990% | 71,610 (New Position) | Filing History |
| 2024-03-11 6:39 pm Purchase | 2024-02-13 | 13G | Evoke Pharma, Inc. EVOK | Bleichroeder LP | 70,781 9.990% | 70,781 (New Position) | Filing History |
| 2024-02-20 4:38 pm Purchase | 2024-02-09 | 13G | Evoke Pharma, Inc. EVOK | Altium Capital Management LLC | 153,186 9.700% | 153,186 (New Position) | Filing History |
| 2024-02-13 06:34 am Purchase | 2024-02-09 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 70,583 9.990% | 70,583 (New Position) | Filing History |
| 2021-05-06 4:20 pm Purchase | 2021-04-30 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 11,814 5.300% | 1,862 (+18.71%) | Filing History |
| 2021-03-25 6:28 pm Sale | 2021-03-19 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 9,952 4.400% | -1,853 (-15.70%) | Filing History |
| 2021-01-20 07:20 am Purchase | 2021-01-14 | 13G | Evoke Pharma, Inc. EVOK | Orin Hirschman | 11,806 5.300% | 11,806 (New Position) | Filing History |